Hydrogen Protects Liver from Cancer Drug Damage in Mice
Hydrogen Mitigated Doxorubicin-Induced Liver Injury via Nrf2/HO-1 Pathway Activation
Research hubs: Digestive System
- Evidence type
- Animal study (mouse)
- Authors
- Meng-Fan Sun, Ji-Xian Song, Miao Tang, Bo-Han Yu, Yao Xiao, Yu-Hui Gao, Zi-Xuan Yao, Ke-Ying An, Zhen-Qun Zhang, Yong-Qing Shen, Ya-Shuo Zhao
- Journal
- International Journal of Molecular Sciences
- Year
- 2026
- DOI
- 10.3390/ijms27062774
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Drug-Induced Liver Injury
- Body System
- Hepatic
This research was done in animals. Results in animals often don't carry over to people.
TL;DR
Hydrogen reduced doxorubicin-induced liver injury by lowering oxidative stress, inflammation, and fibrosis via activation of the Nrf2/HO-1 pathway.
Key Finding
Hydrogen treatment significantly reduced doxorubicin-induced liver damage in mice by activating the Nrf2/HO-1 cellular pathway, which decreased oxidative stress and inflammation.
Summary
Researchers tested whether hydrogen could protect mouse livers from damage caused by doxorubicin, a chemotherapy drug known to harm the liver. They found that hydrogen treatment reduced liver damage, decreased cell death, lowered inflammation, and reduced harmful molecules called free radicals in the liver tissue. The protective effect appeared to work by activating a specific cellular pathway (Nrf2/HO-1) that helps cells defend themselves against damage.
Practical Takeaway
This is an early-stage animal study suggesting hydrogen may have protective effects against chemotherapy-related liver damage. However, because this research was only conducted in mice, not humans, and the study details (duration, sample size) were not reported, it's too early to draw conclusions about whether hydrogen water would protect human livers during cancer treatment. Human clinical trials would be needed to determine if these findings apply to people.
Abstract (excerpt)
Drug-induced liver injury constitutes a major concern within the spectrum of drug-related pathologies. The precise mechanisms underlying doxorubicin (DOX)-induced liver injury remain inadequately elucidated. Hydrogen is known for its selective antioxidant properties and favorable safety profile…